BECN1 and cancer: Beclin-1 expression was lower in cancer cells (Kondo et al., 2005; Shi et al., 2009), heterozygous disruption of BECN1 promotes tumorigenesis (Qu et al., 2003), and its overexpression inhibits tumorigenesis (Liang et al., 1999).